COGNITION THERAPEUTICS ANNOUNCES ISSUANCE OF COMPOSITION OF MATTER PATENT, EXTENDING PROTECTION FOR ZERVIMESINE (CT1812) THROUGH 2045

Reuters · 1d ago

Please log in to view news